Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Number of holders
-
298
-
Total 13F shares, excl. options
-
27,342,861
-
Shares change
-
-364,208
-
Total reported value, excl. options
-
$4,929,918,497
-
Value change
-
-$51,223,771
-
Put/Call ratio
-
33%
-
Number of buys
-
149
-
Number of sells
-
139
-
Price
-
$180.30
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2025
As of 31 Mar 2025 Krystal Biotech, Inc. - COMMON STOCK (KRYS) had 298 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,342,861 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Capital World Investors, Redmile Group, LLC, Frazier Life Sciences Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, and UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC.
This table shows 298 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.